{"id":4592,"date":"2024-01-25T09:20:49","date_gmt":"2024-01-25T09:20:49","guid":{"rendered":"https:\/\/affa.co.id\/global\/?p=4592"},"modified":"2024-01-25T10:45:41","modified_gmt":"2024-01-25T10:45:41","slug":"summary-of-implementation-guideline-and-technical-guideline-of-patent-substantive-examination-in-indonesia","status":"publish","type":"post","link":"https:\/\/affa.co.id\/global\/2024\/01\/25\/summary-of-implementation-guideline-and-technical-guideline-of-patent-substantive-examination-in-indonesia\/","title":{"rendered":"Summary of Implementation Guideline and Technical Guideline of Patent Substantive Examination in Indonesia"},"content":{"rendered":"<h4><b>Summary of Implementation Guideline and Technical Guideline of Patent Substantive Examination in Indonesia<\/b><\/h4>\n<p><img loading=\"lazy\" class=\"aligncenter wp-image-4609 size-full\" src=\"https:\/\/affa.co.id\/global\/wp-content\/uploads\/sites\/10\/2024\/01\/flow_english.png\" alt=\"flow-english-affa-global-eng\" width=\"1028\" height=\"1488\" srcset=\"https:\/\/affa.co.id\/global\/wp-content\/uploads\/sites\/10\/2024\/01\/flow_english.png 1028w, https:\/\/affa.co.id\/global\/wp-content\/uploads\/sites\/10\/2024\/01\/flow_english-207x300.png 207w, https:\/\/affa.co.id\/global\/wp-content\/uploads\/sites\/10\/2024\/01\/flow_english-707x1024.png 707w, https:\/\/affa.co.id\/global\/wp-content\/uploads\/sites\/10\/2024\/01\/flow_english-768x1112.png 768w\" sizes=\"(max-width: 1028px) 100vw, 1028px\" \/><\/p>\n<h4><b>TECHNICAL GUIDELINE<\/b><\/h4>\n<p><span style=\"font-weight: 400;\">Patent Substantive Examinations are conducted within 30 months from the application date and will focus on the following points:<\/span><\/p>\n<p>&nbsp;<\/p>\n<h4><b>DESCRIPTION<\/b><b><\/b><\/h4>\n<ul>\n<li aria-level=\"1\"><b>At Least Should Consist of:<\/b><\/li>\n<\/ul>\n<p style=\"padding-left: 40px;\"><span style=\"font-weight: 400;\">a. Description regarding one way to conduct the invention;<\/span><\/p>\n<p style=\"padding-left: 40px;\"><span style=\"font-weight: 400;\">b. If the description refers to figure, it should use the same reference as used in figures;<\/span><\/p>\n<p style=\"padding-left: 40px;\"><span style=\"font-weight: 400;\">c. Description on how the invention is implemented in industry;<\/span><\/p>\n<p style=\"padding-left: 40px;\"><span style=\"font-weight: 400;\">d. Brief description of invention for understanding regarding the invention;<\/span><\/p>\n<p style=\"padding-left: 40px;\"><span style=\"font-weight: 400;\">e. Mention of technology in closest prior art in the background of invention.<\/span><\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Includes in the Following Order:<\/b><\/li>\n<\/ul>\n<ol>\n<li style=\"list-style-type: none;\">\n<ol>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Technical Field of Invention;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Background of Invention;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Brief Description of Invention;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Brief Description of Drawings (if available);<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Detailed Description of Invention.<\/span><\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Sufficiency of Disclosure<\/b><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Description should disclose the invention clearly, such that those skilled in the art can implement the said invention. This is so that the public can utilize this invention in return for the right granted to the applicant.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The function of the invention should be disclosed.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Prior Art Background<\/b><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Inventor should state what is considered as the closest prior art in the background of the invention. If the search result finds a closer prior art, the closest prior art should be mentioned in the background of the invention.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">In mentioning the prior art the background should be fair and honest and should not be misleading.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h4><b>CLAIMS<\/b><\/h4>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Product Claims vs Process Claims<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">There are only 2 categories of claim:<\/span><\/li>\n<\/ul>\n<ol>\n<li style=\"list-style-type: none;\">\n<ol>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Product Claims: <\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">For a physical entity (object). Products may be a compound, an equipment, a combination of equipment in a system, etc. Product claim cannot be distinguished from prior arts through its method of use.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Process Claims:<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">For an activity (method). Processes may be an activity to produce a product, an activity which use a product, or an activity which use an organism as a subject.<\/span><\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Independent vs Dependent Claims<\/b><\/li>\n<\/ul>\n<ol>\n<li style=\"list-style-type: none;\">\n<ol>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Independent Claim <\/b><span style=\"font-weight: 400;\">consists of all features of the invention which protection is sought . Independent claim does not depend in content on another claim.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Dependent Claim <\/b><span style=\"font-weight: 400;\">consists of all features from independent and\/or other dependent claim and has the same category as the claim which it depends on.<\/span><\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<p style=\"padding-left: 40px;\"><span style=\"font-weight: 400;\">Dependent Claim <\/span><span style=\"font-weight: 400;\">cannot<\/span><span style=\"font-weight: 400;\">:<\/span><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">belong to a different claim category than the claim it depends on;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">be broader than the claim which it depends on;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">contain other features which are not in the claim it depends on;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">refer to a subject matter from another claim for intended purpose; and<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">only refer to a part of the claim which it depends on.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p style=\"padding-left: 40px;\"><span style=\"font-weight: 400;\">Dependent Claim <\/span><span style=\"font-weight: 400;\">can<\/span><span style=\"font-weight: 400;\"> depend on more than 1 claim.<\/span><\/p>\n<p style=\"padding-left: 40px;\"><span style=\"font-weight: 400;\">If a dependent claim disclose a feature which were not described previously, the independent claim should describe this feature, or the dependent claim must first describe this feature.<\/span><\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Product by Process Claims<\/b><\/li>\n<\/ul>\n<p>Product by process claim is not novel just because it is produced by a novel process. Its novelty and inventive step are determined through its own product features.<\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Feature<\/b><\/li>\n<\/ul>\n<p>Product claim should contain product features, process claim should contain process features.<\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Alternative in Claims<\/b><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Claim may refer to alternative forms \u201dand\/or\u201d, but each alternative should have the same basic properties. One alternative must be able to replace another.<\/span><\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Two Parts Form Claim (Preferable Form)<\/b><\/li>\n<\/ul>\n<ol>\n<li style=\"list-style-type: none;\">\n<ol>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>First Part: <\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Preamble consisting of technical features of said invention that is known from previous technology.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Second Part:<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Technical features of invention which distinguish the invention from the previous technology and which protection is sought.<\/span><\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<p style=\"padding-left: 40px;\"><span style=\"font-weight: 400;\">For simple patent, all (tangible) product claim and the dependent claim thereof should be written in two parts form.<\/span><\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Figures and Graphs and References in Claims<\/b><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Claims cannot contain figures or graphs, but may contain tables and mathematical formulas.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">For clarity, notation which refers to figures may be added and should be written uniformly between brackets ( ).<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Parameters in Claims<\/b><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Parameters are values which are properties of a product that can be measured directly. Characterization of product using only parameters are not allowed unless the invention is unable to be described using other means. Method of measurement:<\/span><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Too long to be described in the claim;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Those skilled in the art know which method to use, because there is only one method commonly used;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">All measurement methods yield in the same result.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Consistency<\/b><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Writing of claims should be consistent between one feature to another, e.g.. using present or past participle, using active or passive voice.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Claims should be consistent with the description. The description should contain the same limiting features as the claims.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">If the description states that one feature is essential for the invention, said feature must be included in the independent claim.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">If some embodiments in the description are not included in the claims, the claims may be broaden to include these embodiments or these embodiment may be deleted from the description.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">All terms used in claims should be consistent with the description, all uncommon terms should be defined in the description.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h4><b>AMENDMENT<\/b><\/h4>\n<p><span style=\"font-weight: 400;\">Amendment cannot broaden the scope of the invention (by adding a subject matter), but may be allowed if it is intended to clarify the disclosure.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h4><b>UNITY<\/b><\/h4>\n<p><span style=\"font-weight: 400;\">Invention should have the same common inventive concept. Unity of invention can be considered for the following combination of independent claims:<\/span><\/p>\n<p><span style=\"font-weight: 400;\">a. Product claim, process claim which is specifically used for the manufacture of said product;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">b. Process claim and equipment\/apparatus claim which is specifically designed to conduct said process; and<\/span><\/p>\n<p><span style=\"font-weight: 400;\">c. Product claim, process claim which is specifically used to manufacture said product and equipment\/apparatus claim which is specifically designed to conduct said manufacturing process of said product.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h4><b>PRIORITY<\/b><\/h4>\n<p><span style=\"font-weight: 400;\">Priority rights are granted for the following:<\/span><\/p>\n<p><span style=\"font-weight: 400;\">a. Paris convention or WTO member countries;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">b. Applications claiming priority which is filed within 12 months since the filing date of the priority application;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">c. Previous invention should have been filed by applicant of Indonesian application, or Indonesian applicant should be a rightful surrogate of the applicant of the previous application;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">d. Application should be of the same invention as the previous invention;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">e. Previous invention should be the first application for said invention;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">f. The first application should have been filed on or to a country signing Paris convention or WTO.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h4><b>CHEMISTRY<\/b><b><\/b><\/h4>\n<ul>\n<li aria-level=\"1\"><b>Product by Process Claims<\/b><\/li>\n<\/ul>\n<p style=\"padding-left: 40px;\"><span style=\"font-weight: 400;\">Product by process claims are product claims characterized by process features. Product by process claims are allowed if:<\/span><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Product cannot be described using parameters of product.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Said product is novel.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Product Characterized by Parameters<\/b><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">In section 3.34, product claims should not be characterized by parameters.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Parameters can be used to characterize a product when the product cannot be characterized using other means.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">In certain field such as nanotechnology, to determine the novelty of a product characterized by process, parameter values of the final product can be used as a limiting feature which determine novelty.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Product Characterized by Function<\/b><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Function can be used as limiting feature which determine novelty and inventive step.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Function is used as a limiting feature when the product cannot be characterized by other means.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">One example is claim regarding a catalyst which can only be described through its function in a process.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Measurement of parameters<\/b><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">If the claim disclose a parameter, the claim should specify clearly which method of measurement is used to obtain such parameter.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">For example a claim is considered unclear when it disclose MFR (mass flow rate) as a parameter, meanwhile ISO 1133:2005 specifies two procedures for measurement of MFR, I.e. mass measurement method and displacement measurement method.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h4><b>BIOLOGY<\/b><b><\/b><\/h4>\n<ul>\n<li aria-level=\"1\"><b>Microorganism<\/b><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Microorganisms are yeast, fungi, bacteria, and actinomycetes.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Microorganism includes human cell and plant cell.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Clarity: <\/b><span style=\"font-weight: 400;\">Should be characterized by the correct nomenclature, strain name should be written after the species name.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li aria-level=\"1\"><b>Novelty: <\/b><span style=\"font-weight: 400;\">New strain should be described specifically and the difference with known strain from the same species should be described.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>New species: <\/b><span style=\"font-weight: 400;\">Characterized by taxonomy and phylogenetic tree<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Inventive step: <\/b><span style=\"font-weight: 400;\">A novel microorganism having different taxonomy is inventive.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Non patentable are embryo, seeds, part of plants, tissue, organs, and transgenic plants.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Non-Essential Biological Process<\/b><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Non-essential biological process are biological processes which need human intervention.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Example: Plant tissue isolation method<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Non-patentable are artificial insemination, cross pollination, and other processes which can occur naturally without human intervention.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Microbiological Process<\/b><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Microbiological process are biological processes which use microorganism.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Example: Fermentation<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Nucleotides and Genetic Engineering<\/b><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Nucleotides are DNA, cDNA, primer, gene, vector, transforman.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Patentable nucleotides are isolated nucleotides.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Novelty: <\/b><span style=\"font-weight: 400;\">Examined with BLAST or NCBI.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Inventive Step:<\/b><span style=\"font-weight: 400;\"> if it has different activity at least qualitatively, it is considered inventive.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Gene can be characterized by polynucleotide sequence, amino acid sequence encoded by said polynucleotide, or mutation.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Vector can be characterized by DNA sequence, DNA restriction map, molecular weight, and number of base pair.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Transforman can be characterized with 1 host cell and the introduced gene (sequence).<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h4><b>PHARMACY<\/b><b><\/b><\/h4>\n<ul>\n<li aria-level=\"1\"><b>Pharmaceutical Invention may be in the form of:<\/b><\/li>\n<\/ul>\n<ol>\n<li style=\"list-style-type: none;\">\n<ol>\n<li><b>Physical entity: <\/b><span style=\"font-weight: 400;\">Product or device and composition or compound<\/span><\/li>\n<li><b>Activity: <\/b><span style=\"font-weight: 400;\">Process and method<\/span><\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<p><b><\/b><br \/>\n<b><\/b><\/p>\n<ul>\n<li aria-level=\"1\"><b>Non Limiting or Non Distinguishing Technical Feature:<\/b><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Dosing regimen<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Administration time or frequency<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Patient group<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>New Use for known or existing product<\/b><span style=\"font-weight: 400;\"> is patentable when:\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The protection of claims is directed to compound X with the feature of \u201cdisease Y\u201d as a limiting or distinguishing feature.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">In this case, the claim protection is intended wherein a pharmaceutical industry may produce drug X which is indicated only to treat hypertension.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Drug Mechanism of Action<\/b><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Features solely defined as mechanism of action is considered as too broad and not patentable.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">\u201cActivity or Use\u201d feature which can be used as limiting\/distinguishing features are those intended to treat or prevent certain diseases wherein the efficacy is supported by clinical trial data described in the description.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>New Form<\/b><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">New Form of a known compound is not considered an invention if it does not give any meaningful efficacy improvement and does not have any chemical structural difference in relation to what is known from the compound.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Meaningful efficacy improvement includes improvement in bioavailability, stability, solubility, toxicity, potency, etc. Meaningful efficacy improvement should be supported by experimental data.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Example of New Forms: chirality, crystal\/solvate\/hydrate, salt.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Method of treatment<\/b><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">In vitro, ex vivo, and in silico method of examination or diagnosis are patentable. In vivo method of examination or diagnosis is not patentable.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Non-therapeutic method of treatment is patentable. Therapeutic method of treatment is not patentable.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Method of surgery is not patentable.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Method of medication applied directly to animal and\/or human is not patentable.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li aria-level=\"1\"><b>Natural medicine<\/b><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Product by process claims are allowed when it is difficult to define the product itself except by process features: Example: defining extract by its process of extraction.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Each step in the process of making herbal product affect the quality, safety, and efficacy of the product.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Process features in herbal product preparation can be used in determining the novelty and inventive step.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h4><b>ELECTRO &amp; PHYSICS<\/b><b><\/b><\/h4>\n<ul>\n<li><b>Computer-Implemented Invention<\/b><b><br \/>\n<\/b>Computer implemented invention is an invention which implementation use computer. One or more feature of the invention is fully or partly realized by a computer program. The feature of a computer implemented invention is a program feature. In this invention, source code should not be included in the description or claims. A computer program is considered as an invention if it has technical features:<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It has a technical means, e.g. computer, server, phone, censors, devices.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It produce, when run on a computer, a further technical feature outside of normal physical interaction between computer program (software) and computer.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p style=\"padding-left: 40px;\"><b>Categories:<\/b><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Process Method Product<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">System Device Product (computer program) <\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Computer-readable storage mediasoftware.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Business Method<\/b><b><br \/>\n<\/b><span style=\"font-weight: 400;\">Computer-implemented business method is patentable as long as the subject matter has technical character.<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><b>Artificial Intelligence<\/b><b><br \/>\n<\/b><span style=\"font-weight: 400;\">AI and ML are basically mathematical models which are implemented by software. The technical guideline has not said anything regarding AI and ML.<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Summary of Implementation Guideline and Technical Guideline of Patent Substantive Examination in Indonesia TECHNICAL GUIDELINE Patent Substantive Examinations are conducted within 30 months from the application date and will focus on the following points: &nbsp; DESCRIPTION At Least Should Consist of: a. Description regarding one way to conduct the invention; b. If the description refers to figure, it should use the same reference as used in figures; c. Description on how the invention is implemented in industry; d. Brief description of invention for understanding regarding the invention; e. Mention of technology in closest prior art in the background of invention. &nbsp; Includes in the Following Order: Technical Field of Invention; Background of Invention; Brief Description of Invention; Brief Description of Drawings (if available); Detailed Description of Invention. &nbsp; Sufficiency of Disclosure Description should disclose the invention clearly, such that those skilled in the art can implement the said invention. This is so that the public can utilize this invention in return for the right granted to the applicant.\u00a0 The function of the invention should be disclosed. &nbsp; Prior Art Background Inventor should state what is considered as the closest prior art in the background of the invention. If the search result finds a closer prior art, the closest prior art should be mentioned in the background of the invention. In mentioning the prior art the background should be fair and honest and should not be misleading. &nbsp; CLAIMS Product Claims vs Process Claims There are only 2 categories of claim: Product Claims: For a physical entity (object). Products may be a compound, an equipment, a combination of equipment in a system, etc. Product claim cannot be distinguished from prior arts through its method of use. Process Claims: For an activity (method). Processes may be an activity to produce a product, an activity which use a product, or an activity which use an organism as a subject. &nbsp; Independent vs Dependent Claims Independent Claim consists of all features of the invention which protection is sought . Independent claim does not depend in content on another claim. Dependent Claim consists of all features from independent and\/or other dependent claim and has the same category as the claim which it depends on. Dependent Claim cannot: belong to a different claim category than the claim it depends on; be broader than the claim which it depends on; contain other features which are not in the claim it depends on; refer to a subject matter from another claim for intended purpose; and only refer to a part of the claim which it depends on. Dependent Claim can depend on more than 1 claim. If a dependent claim disclose a feature which were not described previously, the independent claim should describe this feature, or the dependent claim must first describe this feature. &nbsp; Product by Process Claims Product by process claim is not novel just because it is produced by a novel process. Its novelty and inventive step are determined through its own product features. &nbsp; Feature Product claim should contain product features, process claim should contain process features. &nbsp; Alternative in Claims Claim may refer to alternative forms \u201dand\/or\u201d, but each alternative should have the same basic properties. One alternative must be able to replace another. &nbsp; Two Parts Form Claim (Preferable Form) First Part: Preamble consisting of technical features of said invention that is known from previous technology. Second Part: Technical features of invention which distinguish the invention from the previous technology and which protection is sought. For simple patent, all (tangible) product claim and the dependent claim thereof should be written in two parts form. &nbsp; Figures and Graphs and References in Claims Claims cannot contain figures or graphs, but may contain tables and mathematical formulas. For clarity, notation which refers to figures may be added and should be written uniformly between brackets ( ). &nbsp; Parameters in Claims Parameters are values which are properties of a product that can be measured directly. Characterization of product using only parameters are not allowed unless the invention is unable to be described using other means. Method of measurement: Too long to be described in the claim; Those skilled in the art know which method to use, because there is only one method commonly used; All measurement methods yield in the same result. &nbsp; Consistency Writing of claims should be consistent between one feature to another, e.g.. using present or past participle, using active or passive voice. Claims should be consistent with the description. The description should contain the same limiting features as the claims. If the description states that one feature is essential for the invention, said feature must be included in the independent claim. If some embodiments in the description are not included in the claims, the claims may be broaden to include these embodiments or these embodiment may be deleted from the description. All terms used in claims should be consistent with the description, all uncommon terms should be defined in the description. &nbsp; AMENDMENT Amendment cannot broaden the scope of the invention (by adding a subject matter), but may be allowed if it is intended to clarify the disclosure. &nbsp; UNITY Invention should have the same common inventive concept. Unity of invention can be considered for the following combination of independent claims: a. Product claim, process claim which is specifically used for the manufacture of said product; b. Process claim and equipment\/apparatus claim which is specifically designed to conduct said process; and c. Product claim, process claim which is specifically used to manufacture said product and equipment\/apparatus claim which is specifically designed to conduct said manufacturing process of said product. &nbsp; PRIORITY Priority rights are granted for the following: a. Paris convention or WTO member countries; b. Applications claiming priority which is filed within 12 months since the filing date of the priority application; c. Previous invention should have been filed by applicant of Indonesian application, or Indonesian applicant should be a rightful surrogate of the applicant of the previous application;&hellip;<\/p>\n","protected":false},"author":1,"featured_media":4608,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[71,81],"tags":[],"_links":{"self":[{"href":"https:\/\/affa.co.id\/global\/wp-json\/wp\/v2\/posts\/4592"}],"collection":[{"href":"https:\/\/affa.co.id\/global\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/affa.co.id\/global\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/affa.co.id\/global\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/affa.co.id\/global\/wp-json\/wp\/v2\/comments?post=4592"}],"version-history":[{"count":19,"href":"https:\/\/affa.co.id\/global\/wp-json\/wp\/v2\/posts\/4592\/revisions"}],"predecessor-version":[{"id":4622,"href":"https:\/\/affa.co.id\/global\/wp-json\/wp\/v2\/posts\/4592\/revisions\/4622"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/affa.co.id\/global\/wp-json\/wp\/v2\/media\/4608"}],"wp:attachment":[{"href":"https:\/\/affa.co.id\/global\/wp-json\/wp\/v2\/media?parent=4592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/affa.co.id\/global\/wp-json\/wp\/v2\/categories?post=4592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/affa.co.id\/global\/wp-json\/wp\/v2\/tags?post=4592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}